Evidence map›Paper›PMID 30473786›Full record

ArticleAntimicrobial resistance and infection control2018

Antibiotic consumption and antimicrobial resistance in Poland; findings and implications.

Jadwiga Wojkowska-Mach, Brian Godman, Amanda Glassman, Amanj Kurdi, Andrzej Pilc, Anna Rozanska, Szymon Skoczyński, Marta Wałaszek, Tomasz Bochenek

Open access · goldAbstract read
In one paragraph

Article in Antimicrobial resistance and infection control, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
9.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 87 citations in OpenAlex.

  1. Observational
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Observational
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Post-DischargeInternational journal of environmental research and public health · 2022
    Observational
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 6 countries.

Jadwiga Wojkowska-Mach *1Department of Microbiology, Faculty of Medicine, Jagiellonian University Medical College, Czysta 18 Str., 31-121, Krakow, Poland.
Brian Godman2Strathclyde Institute of Pharmacy and Biomedical Sciences, Strathclyde University, G4 ORE, Glasgow, UK.
Amanda Glassman6Center for Global Development, 2055 L Street NW, Washington, DC 20036 USA.
Amanj Kurdi2Strathclyde Institute of Pharmacy and Biomedical Sciences, Strathclyde University, G4 ORE, Glasgow, UK.
Andrzej Pilc8Department of Neurobiology, Institute of Pharmacology, Polish Academy of Sciences, Krakow, Poland.
Anna Rozanska1Department of Microbiology, Faculty of Medicine, Jagiellonian University Medical College, Czysta 18 Str., 31-121, Krakow, Poland.
Szymon Skoczyński10Department of Pneumonology, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland.
Marta Wałaszek11Department of Nursing, Institute of Health Sciences, State Higher Vocational School in Tarnów, Tarnów, Poland.
Tomasz Bochenek *9Department of Drug Management, Faculty of Health Sciences, Jagiellonian University Medical College, Grzegorzecka 20 Str., 31-531, Krakow, Poland.ORCID 0000-0001-9915-7267
Jagiellonian University · PLAkademia Tarnowska · PLCenter for Global Development · USHawler Medical University · IQKarolinska University Hospital · SEMedical University of Silesia · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The problem of inappropriate use of antibiotics and the resulting growth in antimicrobial resistance (AMR) has implications for Poland and the world. The objective of this paper was to compare and contrast antibiotic resistance and antibiotic utilisation in Poland in recent years versus other European countries, including agreed quality indicators, alongside current AMR patterns and ongoing policies and initiatives in Poland to influence and improve antibiotic prescribing. Methods: A quantitative ten-year analysis (2007-2016) of the use of antibiotics based on European Centre for Disease Prevention and Control (ECDC) data combined with a literature review on AMR rates and antimicrobial stewardship initiatives. Results: The system of monitoring AMR and appropriate strategies to address AMR rates remain underdeveloped in Poland. The role of microbiological diagnostics and efforts to prevent infections is currently underestimated by physicians. Overall, Poland had one of the highest rates of total consumption of antibiotics in the analysed European countries. Total consumption of antibacterials for systemic use and relative consumption of beta-lactamase sensitive penicillins were characterized by small but statistically significant average annual increases between 2007 and 2016 (from 22.2 DIDs to 23.9 DIDs and from 0.8 to 1.3%, respectively). Conclusions: The integrated activities around appropriate antibiotic prescribing in the pre- and post-graduate training of physicians and dentists seem to be particularly important, as well as changes in policies on prescribing antibiotics within ambulatory care. AMR and appropriate prescribing of antibiotics should be the focus of health policy actions in Poland.

Indexed as

Anti-Bacterial AgentsDrug Resistance, Bacterialbeta-LactamasesDentistsDrug PrescriptionsDrug UtilizationEuropean UnionHealth PolicyHumansPenicillinsPhysiciansPolandPractice Patterns, Dentists'Practice Patterns, Physicians'Anti-Bacterial Agentsbeta-LactamasesPenicillinsAntibiotic consumptionAntimicrobial resistanceAntimicrobial resistance surveillanceEuropean UnionHealth policyPoland

Identifiers

PMID30473786
PMCPMC6238284
OpenAlexW2901219865

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.